Advertisement
Canada markets open in 4 hours 27 minutes
  • S&P/TSX

    21,714.54
    -297.08 (-1.35%)
     
  • S&P 500

    5,035.69
    -80.48 (-1.57%)
     
  • DOW

    37,815.92
    -570.17 (-1.49%)
     
  • CAD/USD

    0.7263
    +0.0002 (+0.03%)
     
  • CRUDE OIL

    80.73
    -1.20 (-1.46%)
     
  • Bitcoin CAD

    78,495.50
    -6,825.74 (-8.00%)
     
  • CMC Crypto 200

    1,224.26
    -114.81 (-8.58%)
     
  • GOLD FUTURES

    2,295.10
    -7.80 (-0.34%)
     
  • RUSSELL 2000

    1,973.91
    -42.12 (-2.09%)
     
  • 10-Yr Bond

    4.6860
    +0.0720 (+1.56%)
     
  • NASDAQ futures

    17,468.00
    -103.25 (-0.59%)
     
  • VOLATILITY

    15.86
    +0.21 (+1.34%)
     
  • FTSE

    8,163.76
    +19.63 (+0.24%)
     
  • NIKKEI 225

    38,274.05
    -131.61 (-0.34%)
     
  • CAD/EUR

    0.6803
    +0.0001 (+0.01%)
     

New Strong Buy Stocks for April 17th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Byrna Technologies Inc. BYRN:  This non-lethal defense technology companyhas seen the Zacks Consensus Estimate for its current year earnings increasing 157.1% over the last 60 days.

Byrna Technologies Inc. Price and Consensus

Byrna Technologies Inc. Price and Consensus
Byrna Technologies Inc. Price and Consensus

Byrna Technologies Inc. price-consensus-chart | Byrna Technologies Inc. Quote

Y-mAbs Therapeutics, Inc. YMAB: This commercial-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 42.7% over the last 60 days.

Y-mAbs Therapeutics, Inc. Price and Consensus

Y-mAbs Therapeutics, Inc. Price and Consensus
Y-mAbs Therapeutics, Inc. Price and Consensus

Y-mAbs Therapeutics, Inc. price-consensus-chart | Y-mAbs Therapeutics, Inc. Quote

ADVERTISEMENT

Sandstorm Gold Ltd. SAND: This gold royalty company has seen the Zacks Consensus Estimate for its current year earnings increasing 16.7% over the last 60 days.

Sandstorm Gold Ltd Price and Consensus

Sandstorm Gold Ltd Price and Consensus
Sandstorm Gold Ltd Price and Consensus

Sandstorm Gold Ltd price-consensus-chart | Sandstorm Gold Ltd Quote

Corcept Therapeutics Incorporated CORT: This pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 27.8% over the last 60 days.

Corcept Therapeutics Incorporated Price and Consensus

Corcept Therapeutics Incorporated Price and Consensus
Corcept Therapeutics Incorporated Price and Consensus

Corcept Therapeutics Incorporated price-consensus-chart | Corcept Therapeutics Incorporated Quote

Enveric Biosciences, Inc. ENVB: This biotechnology company has seen the Zacks Consensus Estimate for its next year earnings increasing 25.6% over the last 60 days.

Enveric Biosciences, Inc. Price and Consensus

Enveric Biosciences, Inc. Price and Consensus
Enveric Biosciences, Inc. Price and Consensus

Enveric Biosciences, Inc. price-consensus-chart | Enveric Biosciences, Inc. Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Corcept Therapeutics Incorporated (CORT) : Free Stock Analysis Report

Sandstorm Gold Ltd (SAND) : Free Stock Analysis Report

Y-mAbs Therapeutics, Inc. (YMAB) : Free Stock Analysis Report

Byrna Technologies Inc. (BYRN) : Free Stock Analysis Report

Enveric Biosciences, Inc. (ENVB) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research